Chronic inflammatory demyelinating polyneuropathy in childhood

Pediatric Neurology

Volumn 24, Issue 3, 2001, Pages 177-182

  Connolly, Anne M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PREDNISONE;

CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DYSESTHESIA; HUMAN; HUMORAL IMMUNITY; INCIDENCE; MUSCLE WEAKNESS; NERVE BLOCK; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE;

ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; MALE; NEURAL CONDUCTION; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDNISONE; PREVALENCE; PROGNOSIS;

EID: 0035066566     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(00)00237-X     Document Type: Review

References (54)

1. An infant with chronic, relapsing polyneuropathy responsive to steroids
2. Chronic inflammatory demyelinating polyneuropathy of infancy; A corticosteroid responsive disorder
3. Childhood chronic inflammatory demyelinating neuropathies (CIDP); Clinical course and long term follow up
4. Chronic inflammatory demyelinating polyradiculoneuropathy in children; II. Long-term follow-up, with comparison to adults
5. Chronic inflammatory demyelinating polyradiculoneuropathy in children; I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults
6. Childhood chronic inflammatory demyelinating polyneuropathy; Clinical course and long-term outcome
7. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood
8. Response of CSF IgG to steroids in an 18-month-old with chronic inflammatory polyradiculoneuropathy
9. Chronic inflammatory demyelinating polyneuropathy
10. Chronic inflammatory demyelinating polyradiculoneuropathy; A prevalence study in south east England
11. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia
12. Neuropathy of metachromatic leukodystrophy; Improvement with immunomodulation
13. Chronic inflammatory demyelinating polyneuropathy in childhood
14. The spectrum of chronic inflammatory demyelinating polyneuropathy
15. A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy
16. Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy
17. Nerve conduction studies in infants and children
18. Electrophysiologic features of inherited demyelinating neuropathies; A reappraisal
19. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies
20. Prednisone improves chronic inflammatory demyelinating polyneuropathy more than no treatment
21. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy
22. Immunohistochemical and ultrastructural classification of peripheral neuropathies with onion-bulbs
23. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin
24. Antibodies to acidic glycolipids in Guillain-Barre syndrome an chronic inflammatory demyelinating polyneuropathy
25. Investigation of serum response to myelin and non-myelin components in inflammatory neuropathies
26. High titer selective serum anti-β-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy
27. Serum IgM monoclonal autoantibody binding to the 301-314 amino acid epitope of β-tubulin; Clinical association with slowly progressive demyelinating polyneuropathy
28. Anti-tubulin autoantibodies in acquired demyelination polyneuropathies
29. Anti-PMP22 antibodies in patients with inflammatory neuropathy
30. Natural autoantibodies; From 'horror autotoxicus' to 'gnothi seauton.'
31. The natural autoantibodies system; Between hypotheses and facts
32. High frequency of natural autoantibodies in normal newborn mice
33. 1
34. Evidence for somatic selection of natural autoantibodies
35. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes
36. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice
37. Chronic inflammatory polyneuropathy; reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulins
38. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients
39. Recurrent polyneuropathies and their corticosteroid treatment
40. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy
41. Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange
42. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy; A double-blind, placebo-controlled, crosssover study
43. Chronic relapsing (dysimmune) polyneuropathy; pathogenesis and treatment
44. Chronic inflammatory demyelinating polyradiculoneuropathy
45. Chronic inflammatory demyelinating polyneuropathy; Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy
46. Long-term plasmapheresis therapy is effective and safe in children with chronic relapsing dysimmune polyneuropathy
47. Chronic inflammatory demyelinating polyneuropathy in childhood; Clinical and electrophysiological features
48. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
49. Interferon beta normalizes suppressor cell function in dysimmune neuropathies
50. Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy
51. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy
52. The pathological basis of conduction block in human neuropathies